5 times pursuing the first outcome evaluation working day. In combination with PTSD symptom improvement, the ketamine group exhibited markedly greater reduction in comorbid depressive indications compared to the midazolam group, which is notable given the high comorbidity of depression in individuals with PTSD. Study findings further prompt that recurring https://charlesc333xla0.blogscribble.com/profile